CompoAtlas

BC Supplements - Hair, Scalp & Skin

Food supplement declared in France, declaration No 2023-4-40

BC Supplements - Hair, Scalp & Skin, from Henkel AG & Co. KGaA, is a food supplement declared in France. Status: withdrawn from the market on 12 July 2025. Main ingredients: Pantothenic acid (vitamin B5), Biotin (vitamin B8), Copper, Selenium, Vitamin B12. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
Henkel AG & Co. KGaA
Status
Withdrawn from the market on 12 July 2025
Form
Capsule
Daily dose
1 gélule
Directions for use
1 gélule par jour
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Pregnant women, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Skin

Declaration 328445, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
L-cystinenot declared
Ubiquinonenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothenate, calciumPantothenic acid (vitamin B5)no limit (insufficient data)dose annulled by the French Council of State in 2011
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
cupric citrateCopper5,000 µg2,000 µg
L-selenomethionineSelenium255 µg50 µg
cyanocobalaminVitamin B12no adverse effect defineddose annulled by the French Council of State in 2011
riboflavinVitamin B2 (riboflavin)no limit (insufficient data)dose annulled by the French Council of State in 2011
pyridoxine hydrochlorideVitamin B612 mg2 mg
calcium-L-ascorbateVitamin Cno limit (insufficient data)180 mg
D-alpha-tocopheryl acetateVitamin E300 mg30 mg
zinc picolinateZinc25 mg15 mg

Additives

E464, E551

Other ingredients

Pisum sativum L.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Tenir hors de portée des enfants. Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas être utilisés comme substitut d'une alimentation variée et équilibrée et d'un mode de vie sain. Convient uniquement aux adultes. L'utilisation simultanée d'autres compléments contenant du zinc doit être évitée. Si vous êtes enceinte, allaitez ou suivez un traitement médical, veuillez consulter un médecin avant d'utiliser ce produit.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ubiquinone
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    Sources cited by Health Canada (2)
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (3)
    • Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “BC Supplements - Hair, Scalp & Skin: composition and regulation”, https://compoatlas.com/en/supplements/products/328445-bc-supplements-hair-scalp-skin, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line